Insider · CIK 0001563992
Diana Hausman
director
Files at IMRX (Immuneering Corp). First filing Jul 7, 2025, latest Jul 7, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +2,500 | $3.60 | $8,989 | 2,500 | Jul 7, 2025 |
| Jul 2, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stockindirect: By spouse | +3,000 | $3.62 | $11k | 3,000 | Jul 7, 2025 |
| Jun 13, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +33,350 | $0.00 | $0 | 33,350 | Jun 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.